Semaglutide
Research OnlyGLP-1 Receptor Agonist
Semaglutide is a potent GLP-1 receptor agonist that mimics the action of the endogenous hormone GLP-1. It regulates appetite and food intake by acting on the brain's appetite centers and slows gastric emptying to promote fullness.
Dosing Schedule
| Week | Dose | Units (U-100) |
|---|---|---|
| 1-4 | 0.25 mg | 10 units |
| 5-8 | 0.50 mg | 20 units |
| 9-12 | 1.00 mg | 40 units |
| 13-16 | 1.70 mg | 68 units |
| 17+ | 2.40 mg | 96 units |
Frequency: Inject once weekly subcutaneously.
When you BUY Semaglutide, you want to know that it's pure. We recommend using trusted suppliers for your research needs.
Visual representation of the dosage ramp-up over the cycle duration.
Reconstitution
2ml
2.5 mg/mL
5 mg
Add 2.0 mL bacteriostatic water to a 5mg vial for a concentration of 2.5 mg/mL.
Administration
Timing Strategy
Administer once weekly on the same day each week.
Cycle Length
Titrate dose every 4 weeks based on tolerance. Maximum dose is 2.4mg weekly.
Research Benefits
Selectively binds to GLP-1 receptors to reduce hunger, increase satiety, and improve glycemic control.
Storage Guidelines
Lyophilized: Store at -20°C (-4°F).
Reconstituted: Refrigerate at 2-8°C (36-46°F). Do not freeze.
Research Purposes Only
This information is for educational and research purposes only. These compounds are not approved for human consumption. Always consult with a qualified professional and adhere to local regulations regarding research chemicals.
Concentration
2.50 mg/mL
(2500 mcg/mL)
Injection Volume
0.10 mL
Draw to this mark on U-100 Syringe
Visual representation on a standard U-100 Insulin Syringe